Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05580614 · ClinicalTrials.gov registry record · NA

Paired tVNS With ERP in OCD

A NA study of OCD, sponsored by University of Florida.

Recruiting
Registry status
NA
Development phase
56
Enrollment target
1
Study location

NCT05580614 is a NA study of OCD that is actively recruiting participants, run by University of Florida. The registered enrollment target is 56 participants, below the 815-participant average among 18 other OCD trials with a reported enrollment target (93% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05580614, a NA study of OCD, is actively recruiting participants, sponsored by University of Florida.

RECRUITING
Registry status
NA
Development phase
56 participants
Enrollment target
1
Study location

Study Summary

In the proposed investigation, the investigator will develop pilot data for the use of tVNS (transcutaneous vagal nerve stimulation) to enhance efficacy of exposure and response prevention therapy (ERP) to improve treatment success in patients with OCD. This data will include tolerability information from therapists and patients with OCD, effect sizes on real world clinical outcomes for the combinatory treatment, and mechanistic data on brain changes associated with treatment.

Conditions Studied

Interventions

  • DEVICE Sham
  • DEVICE tVNS

Study Locations (1)

Florida

  • University of Florida - Gainesville

Trial Details

FieldValue
Enrollment Target 56 participants
Start Date 2022-06-27
Est. Completion 2026-08-31
Phase NA

Sponsor

University of Florida

1,106 total trials

What the Registry Record Tells You About NCT05580614

The ClinicalTrials.gov registry entry for NCT05580614 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 56 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 815-participant average among 18 other OCD trials with a reported enrollment target (93% lower). The listed sponsor is University of Florida, which has 1,106 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with OCD appearing as the primary indexed condition, and to 2 interventions - of which Sham is the first listed.

NCT05580614 reports 1 study location spanning 1 distinct geographic area - top geographies include Florida.

Frequently Asked Questions

What is clinical trial NCT05580614 about?

NCT05580614 is a clinical study titled "Paired tVNS With ERP in OCD". In the proposed investigation, the investigator will develop pilot data for the use of tVNS (transcutaneous vagal nerve stimulation) to enhance efficacy of exposure and response prevention therapy (ERP) to improve treatment success in patients with OCD. This data will include tolerability informatio...

What is the current status of trial NCT05580614?

This trial is currently recruiting. It is a NA study. The enrollment target is 56 participants. The study started on 2022-06-27. Estimated completion is 2026-08-31.

What conditions does trial NCT05580614 study?

This clinical trial studies the following conditions: OCD.

What interventions are being tested in trial NCT05580614?

The interventions under investigation include: Sham (DEVICE), tVNS (DEVICE).

Who is sponsoring clinical trial NCT05580614?

This trial is sponsored by University of Florida, which has 1,106 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05580614 being conducted?

This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for OCD

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.